Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-033265
Filing Date
2017-05-17
Accepted
2017-05-17 17:21:54
Documents
1
Period of Report
2017-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7595
  Complete submission text file 0001209191-17-033265.txt   9235
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Ekman Lars (Reporting) CIK: 0001376117 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 17852689